We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
Stockal+Disclaimer.pdf
3 own
5 watching
Current Price
$2.3
$0.05
(2.46%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
213.17M
52-Week High
11.91
52-Week Low
2.02
Average Volume
0.8M
Dividend Yield
--
P/E Ratio
--
Market Capitalization213.17M
52-Week High11.91
52-Week Low2.02
Average Volume0.8M
Dividend Yield--
P/E Ratio--
What does the Stockal+Disclaimer.pdf do?
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Globe Newswire
6days ago
VANCOUVER, Wash. and NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today announced the company will be participating in the upcoming Berenberg Discover AI Seminar in New York, NY. Absci management is scheduled to participate in a...
Globe Newswire
20days ago
Milestone achievement and progress continues in previously announced Merck collaboration Further strengthened executive leadership and Board of Directors VANCOUVER, Wash. and NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a generative AI drug creation company, today ...
GeekWire
26days ago
Seattle startup Syndio hired Milan Parikh as its new chief financial officer. Parikh is a longtime finance leader and was most recently CFO at telecommunications software company MATRIXX. He also was CFO at Fan TV, which was acquired by TiVo. Founded in 2017, Syndios data-science powered software is...
Globe Newswire
1month ago
VANCOUVER, Wash. and NEW YORK, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), leaders in the protein drug creation revolution harnessing generative AI and scalable biological data to design better therapeutics, faster, today announced the company will be participating in the ...
PR Newswire
3 months ago
Thinking about buying stock in SmileDirectClub, Purecycle Technologies, Absci Corp, Jumia Technologies, or Porch Group? Thinking about buying stock in SmileDirectClub, Purecycle Technologies, Absci Corp, Jumia Technologies, or Porch Group? PR Newswire NEW YORK, Aug. 12, 2022 NEW YORK, Aug. 12, 2022...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$2.3
$0.05
(2.46%)
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00